Sytheon Ltd
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Mar 12 to 19, 2027 · next Mar 12
- 1 fee due Jul 9, 2027The maintenance fee for Compositions and methods for reducing hair loss and increasing hair growth (US 11,865,087) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Skin enhancing compositions and methods (US 10,568,819) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases (US 10,597,402) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,529,967 | Sunscreen compositions and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 8,859,021 | Skin appearance through gene manipulation In force · From the USPTO record | In force | From the USPTO record | |
| US 8,496,917 | Compositions and methods for improving skin appearance In force · From the USPTO record | In force | From the USPTO record | |
| US 8,617,528 | Compositions and methods for stabilizing ingredients using 2,4-pentanedione compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 10,597,402 | Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 11,312,725 | Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 11,753,414 | Compositions and methods for treating atopic dermatitis In force · From the USPTO record | In force | From the USPTO record | |
| US 11,753,415 | Compositions and methods for treating atopic dermatitis In force · From the USPTO record | In force | From the USPTO record | |
| US 12,012,416 | Compositions and methods for treating atopic dermatitis In force · From the USPTO record | In force | From the USPTO record | |
| US RE50,049 | Compositions and Methods for Treating Psoriasis In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 18: 1 lapsed for an unpaid fee · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 no status recorded